Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Current Assets (2022 - 2026)

Rallybio's Current Assets history spans 4 years, with the latest figure at $61.3 million for Q4 2025.

  • On a quarterly basis, Current Assets fell 9.71% to $61.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $61.3 million, a 9.71% decrease, with the full-year FY2025 number at $61.3 million, down 9.71% from a year prior.
  • Current Assets hit $61.3 million in Q4 2025 for Rallybio, down from $66.6 million in the prior quarter.
  • Over the last five years, Current Assets for RLYB hit a ceiling of $179.5 million in Q4 2022 and a floor of $50.3 million in Q2 2025.
  • Historically, Current Assets has averaged $100.5 million across 4 years, with a median of $91.4 million in 2024.
  • The widest YoY moves for Current Assets: up 9.71% in 2025, down 45.03% in 2025.
  • Tracing RLYB's Current Assets over 4 years: stood at $179.5 million in 2022, then plummeted by 36.05% to $114.8 million in 2023, then tumbled by 40.9% to $67.8 million in 2024, then fell by 9.71% to $61.3 million in 2025.
  • Business Quant data shows Current Assets for RLYB at $61.3 million in Q4 2025, $66.6 million in Q3 2025, and $50.3 million in Q2 2025.